Probiotec
(ASX) PBP
This security has been delisted. This page is retained for historical reference.
PBP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowPBP Financials
Key Financial Metrics (TTM)
Gross Margin
29%
Operating Margin
10%
Net Income Margin
5%
Return on Equity
13%
Return on Capital
15%
Return on Assets
5%
Earnings Yield
N/A
Dividend Yield
3.61%
Payout Ratio
47.98%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$61.61M
Operating Income
$20.73M
EBITDA
$35.39M
Operating Cash Flow
$17.17M
Capital Expenditure
$10.14M
Free Cash Flow
$7.02M
Cash & ST Invst.
$14.05M
Total Debt
$87.90M
Probiotec Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$113.96M
+33.8%
Gross Profit
$29.11M
+15.1%
Gross Margin
25.55%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
111
N/A
Net Income
$3.13M
-29.6%
EBITDA
$12.80M
+30.3%
Quarterly Fundamentals
Net Cash
$73.27M
-10.0%
Accounts Receivable
$34.73M
+45.3%
Inventory
$22.45M
+54.6%
Long Term Debt
$44.56M
+505.4%
Short Term Debt
$1.80M
+15.4%
Return on Assets
4.68%
N/A
Return on Invested Capital
14.63%
N/A
Free Cash Flow
$3.87M
-57.7%
Operating Cash Flow
$9.26M
-22.8%